Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Depreciation & Amortization (CF) (2017 - 2021)

Cogent Biosciences has reported Depreciation & Amortization (CF) over the past 5 years, most recently at $21000.0 for Q4 2021.

  • Quarterly results put Depreciation & Amortization (CF) at $21000.0 for Q4 2021, up 23.53% from a year ago — trailing twelve months through Dec 2021 was $100000.0 (down 86.11% YoY), and the annual figure for FY2025 was $2.6 million, up 4.0%.
  • Depreciation & Amortization (CF) for Q4 2021 was $21000.0 at Cogent Biosciences, down from $48000.0 in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for COGT hit a ceiling of $352000.0 in Q4 2018 and a floor of $14000.0 in Q2 2021.
  • Median Depreciation & Amortization (CF) over the past 5 years was $297500.0 (2017), compared with a mean of $230250.0.
  • Peak annual rise in Depreciation & Amortization (CF) hit 23.53% in 2021, while the deepest fall reached 95.1% in 2021.
  • Cogent Biosciences' Depreciation & Amortization (CF) stood at $307000.0 in 2017, then increased by 14.66% to $352000.0 in 2018, then fell by 10.8% to $314000.0 in 2019, then tumbled by 94.59% to $17000.0 in 2020, then rose by 23.53% to $21000.0 in 2021.
  • The last three reported values for Depreciation & Amortization (CF) were $21000.0 (Q4 2021), $48000.0 (Q3 2021), and $14000.0 (Q2 2021) per Business Quant data.